COVID-SARS Research Questions

How common is having an initial heavy cold, an interim period of no symptoms and then respiratory symptoms, followed by a period of extreme fatigue as antibodies are produced?

Do people who have had a more sever form of the virus have long term immunity (more so than a vaccine)? Is the best way to gain immunity to have it?

Do medical personnel who have been sick need PPE for their own safety or for the reputational value, or esprit de corps, of the profession?

For resuscitated victims, both for SARS and generally speaking, what is the death rate? What is the cost in terms of resources diverted for not letting people who came in dead stay dead if there is almost certainty of death?

For patients requiring hospitalization or who have extended illness, what is the mortality between those who have, in the past, adhered to CDC guidelines on sanitation vs. those who have not? What is the rate of prior respiratory infection, other infection, for each group?

Should antibody testing in the population at large show widespread immunity from prior illness, is a rebound effect more or less likely? What would such findings do to the enforcement of social distance (and adherence to CDC guidance on avoiding infections generally (and do the latter disable immune systems more than limiting disease spread)?

Do the CDC and NIH consider these to be inconvenient questions? Are they considered dangerous questions, likely to put people at risk? If so, why? Is this a social or epidemiological question?